145 related articles for article (PubMed ID: 30723271)
1. A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms.
Sharkawy RE; Bayoumi A; Metwally M; Mangia A; Berg T; Romero-Gomez M; Abate ML; Irving WL; Sheridan D; Dore GJ; Spengler U; Lampertico P; Bugianesi E; Weltman M; Mollison L; Cheng W; Riordan S; Santoro R; Gallego-Durán R; Fischer J; Nattermann J; D'Ambrosio R; McLeod D; Powell E; Latchoumanin O; Thabet K; Najim MAM; Douglas MW; Liddle C; Qiao L; George J; Eslam M;
Sci Rep; 2019 Feb; 9(1):1439. PubMed ID: 30723271
[TBL] [Abstract][Full Text] [Related]
2. DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection.
Burza MA; Motta BM; Mancina RM; Pingitore P; Pirazzi C; Lepore SM; Spagnuolo R; Doldo P; Russo C; Lazzaro V; Fischer J; Berg T; Aghemo A; Cheroni C; De Francesco R; Fargion S; Colombo M; Datz C; Stickel F; Valenti L; Romeo S
Hepatology; 2016 Feb; 63(2):418-27. PubMed ID: 26517016
[TBL] [Abstract][Full Text] [Related]
3. Diversity of the association of serum levels and genetic variants of MHC class I polypeptide-related chain A with liver fibrosis in chronic hepatitis C.
Huang CF; Huang CI; Yeh ML; Wang SC; Chen KY; Ko YM; Lin CC; Tsai YS; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Yu ML
Oncotarget; 2017 May; 8(20):32618-32625. PubMed ID: 28427234
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in MICA, but not in DEPDC5, HCP5 or PNPLA3, are associated with chronic hepatitis C-related hepatocellular carcinoma.
Hai H; Tamori A; Thuy LTT; Yoshida K; Hagihara A; Kawamura E; Uchida-Kobayashi S; Morikawa H; Enomoto M; Murakami Y; Kawada N
Sci Rep; 2017 Sep; 7(1):11912. PubMed ID: 28928439
[TBL] [Abstract][Full Text] [Related]
5. Disheveled EGL-10 and pleckstrin domain-containing 5 rs1012068 T/G gene polymorphism among Egyptian chronic HCV-infected patients: disease progression and related complications.
Farhan HM; Abougabal K; Gaber HF; Attia D
Egypt J Immunol; 2022 Jul; 29(3):36-43. PubMed ID: 35758967
[TBL] [Abstract][Full Text] [Related]
6. Association between MICA rs2596542 Polymorphism with the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients.
Marangon CG; de Bitencorte JT; Michita RT; Lunge VR; Dos Santos DC; Álvares-da-Silva MR; Simon D
Pathol Oncol Res; 2020 Jul; 26(3):1519-1525. PubMed ID: 31471884
[TBL] [Abstract][Full Text] [Related]
7. Association Between MICA Gene Variants and the Risk of Hepatitis C Virus-Induced Hepatocellular Cancer in a Sicilian Population Sample.
Augello G; Balasus D; Fusilli C; Mazza T; Emma MR; Giannitrapani L; Agliastro R; Cervello M; Montalto G
OMICS; 2018 Apr; 22(4):274-282. PubMed ID: 29584564
[TBL] [Abstract][Full Text] [Related]
8. Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma.
Lange CM; Bibert S; Dufour JF; Cellerai C; Cerny A; Heim MH; Kaiser L; Malinverni R; Müllhaupt B; Negro F; Semela D; Moradpour D; Kutalik Z; Bochud PY;
J Hepatol; 2013 Sep; 59(3):504-9. PubMed ID: 23665287
[TBL] [Abstract][Full Text] [Related]
9. Variations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia.
Al-Anazi MR; Matou-Nasri S; Abdo AA; Sanai FM; Khan MQ; Albenmousa A; Al-Ashgar HI; Khalaf NZ; Al-Ahdal MN; Al-Qahtani AA
BMC Infect Dis; 2014 Dec; 14():632. PubMed ID: 25551790
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.
Luo X; Wang Y; Shen A; Deng H; Ye M
BMC Med Genet; 2019 Aug; 20(1):142. PubMed ID: 31419949
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
El-Bassiouny AE; Zoheiry MM; Nosseir MM; El-Ahwany EG; Ibrahim RA; El-Bassiouni NE
MedGenMed; 2007 Aug; 9(3):45. PubMed ID: 18092051
[TBL] [Abstract][Full Text] [Related]
12. Genetics Variants and Serum Levels of MHC Class I Chain-related A in Predicting Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients Post Antiviral Treatment.
Huang CF; Huang CY; Yeh ML; Wang SC; Chen KY; Ko YM; Lin CC; Tsai YS; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Yu ML
EBioMedicine; 2017 Feb; 15():81-89. PubMed ID: 27998720
[TBL] [Abstract][Full Text] [Related]
13. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
[TBL] [Abstract][Full Text] [Related]
14. Genetic variation at -1878 (rs2596542) in MICA gene region is associated with chronic hepatitis B virus infection in Saudi Arabian patients.
Al-Qahtani AA; Al-Anazi M; Abdo AA; Sanai FM; Al-Hamoudi W; Alswat KA; Al-Ashgar HI; Khalaf N; Viswan N; Al-Ahdal MN
Exp Mol Pathol; 2013 Dec; 95(3):255-8. PubMed ID: 23994040
[TBL] [Abstract][Full Text] [Related]
15. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
Radwan MI; Pasha HF; Mohamed RH; Hussien HI; El-Khshab MN
Cytokine; 2012 Oct; 60(1):271-6. PubMed ID: 22682513
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma.
Kumar V; Kato N; Urabe Y; Takahashi A; Muroyama R; Hosono N; Otsuka M; Tateishi R; Omata M; Nakagawa H; Koike K; Kamatani N; Kubo M; Nakamura Y; Matsuda K
Nat Genet; 2011 May; 43(5):455-8. PubMed ID: 21499248
[TBL] [Abstract][Full Text] [Related]
17. Association of serial serum major histocompatibility complex class I chain-related A measurements with hepatocellular carcinoma in chronic hepatitis C patients after viral eradication.
Huang CF; Wang SC; Yeh ML; Huang CI; Tsai PC; Lin ZY; Chen SC; Dai CY; Huang JF; Chuang WL; Chen A; Yu ML
J Gastroenterol Hepatol; 2019 Jan; 34(1):249-255. PubMed ID: 29932235
[TBL] [Abstract][Full Text] [Related]
18. Role of fibrogenic markers in chronic hepatitis C and associated hepatocellular carcinoma.
El-Bassiouni NE; Nosseir MM; Madkour ME; Zoheiry MM; Bekheit IW; Ibrahim RA; Ibrahim IM; El Bassiouny AE
Mol Biol Rep; 2012 Jun; 39(6):6843-50. PubMed ID: 22318548
[TBL] [Abstract][Full Text] [Related]
19. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
Feili X; Wu S; Ye W; Tu J; Lou L
Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
